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1. Introduction 
The first component of complement, Cl*, is a 
Ca”-dependent complex of three subunits, Clq, Clr 
and Cls, and triggers a series of immunological reaction, 
upon activation by binding to immune complexes 
[ 11. At least two intramolecular sequential reactions 
are known to be related with the activation of Cl; 
activation of Clr [2] and activation of Cls by activated 
ci; [3]. 
Recently, Sakai and Stroud [4] and Valet and 
Cooper [5] reported that the activation of Cls by Cif 
is a proteolytic process; the zymogen Cls, which is a 
single polypeptide chain, is converted to active CG, 
which is composed of two polypeptide chains connect- 
ed by disulfide bond. C&is a DFP-sensitive serine 
protease and represents the biological activities of 
activated fi [6]. 
There is general agreement about the activation 
reaction of various zymogens in blood plasma; activa- 
tion of zymogen is associated with the formation of 
a new NHz-terminal sequence which is homologous 
to those of pancreatic serine proteases [7,8]. 
* The symbols for complement components used in this 
paper conform to the recommendations of the World 
Health Organization Committee on complement nomen- 
clature; (1970) Immunochemistry 7,137-142. Activated 
components are indicated by placing a bar over the 
numeral which refers to the active component or subunit. 
Other abbreviations used are ACD, acid titrated dextrose; 
ATEE, N-oracetyl&tyrosine ethylester; SDS, sodium 
dodecylsulfate; DFP, diisopropylfluorophosphate; EDTA, 
ethylenediamine tetraacetate. 
So, it is of interest to see whether a homologous 
NHz-terminal sequence is also liberated as the new 
NHz-terminal after the activation of Cls to CL. 
To this end, we here describe a simple method for 
purification of CK from ACD-human plasma and 
determine the NH&erminal sequences of CG and the 
zymogen Cls. 
The data indicate that human CG has two poly- 
peptide chains; the heavy chain having the NI-12- 
terminal sequence of the zymogen Cls and the light 
chain having a new NHz-terminal sequence which is 
homologous to those of other plasma and pancreatic 
proteases. 
2. Materials and methods 
Gut-dated human ACDblood was obtained from 
the Blood Center of the Japanese Red Cross, Hokkaido. 
IgGSepharose 6B which was used in the affinity 
chromatography of C! was prepared by the method 
of Bing [9]. The zymogen Cls was purified from 
human plasma according to the method of Sakai and 
Stroud [4] with a slight modifications; the precipita- 
tion of euglobulins from human plasma and extraction 
of Cls from the euglobulins were done in the presence 
of 5 mM benzamidine, in order to avoid the spon- 
taneous activation of Cls during the isolation 
procedure. 
Two pure polypeptide chains of &were isolated 
by analytical scale polyacrylamide gel electrophoresis 
[lo] of a which had been treated with 0.1 M 2- 
mercaptoethanol in 0.1 M phosphate buffer, pH 7.5, 
containing 1% SDS at 37’C for 1 hr. 
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The NHz-terminal sequences of Cls and CKwere 
determined by the SDSdansyl-Edman microtechnique 
of Weiner et al. [lo]. Dan&amino acids were iden- 
tified by thin-layer microchromatography on Poly 
amide layer (Chen Chin Co.), using solvent systems 
reported [ 10,111. Dansylchloride and standard dansyl- 
amino acids were obtained from Seikagaku Kogyo 
Co., Japan. Molecular weights of the polypeptide 
chains were estimated by the method of Weber and 
Osbom [ 121 with standard proteins of known 
molecular weight (protein calibration kit II, 
Boehringer Co.). 
3. Results 
3.1. Ptrrification of human Cl; 
The various steps in the purification of human CL 
are shown in table 1. As reported in a previous paper 
[ 131, Cl in human plasma was precipitated as the 
spontaneously activated form with polyethylene 
glzol and adsorbed on a col_umn of IgG-Sepharose. 
Cls was then released from Cl on IgG-Sepharose with 
EDTA as described by Sledge and Bing [ 141 (fig.la) 
and finally purified by chromatography on DEAE- 
cellulose (fig. 1 b). CT;, which was simultaneously 
released from Cion IgC-Sepharose, was recovered in 
the unadsorbed fraction of DEAE-cellulose chromato- 
graphy . 
The purification was about 200-fold with an 
overall yield of 23%, relative to the first precipitate 
with polyethylene glycol. The entire procedure is 
reproducible and can be done within 72 hr. 
6 prepared in this manner yielded a single band 
after polyacrylamide gel electrophoresis at pH 9.5 
(fig.2a) or at pH 7.4 in the presence of SDS (fig2b). 
The two-chain structure of Cls was evident on SDS- 
polyacrylamide gel electrophoresis of the 2-mercapto- 
ethanol-treated CL (fig.2c). The mol wts of Cl, and 
the two chains, termed heavy and light chains, were 
estimatedtobe 10.5X 104,6.8X lo4 and3.4X 104, 
respectively. 
3.2. The NH*-terminal sequences of the heavy and 
light chains of &and the zymogen Cls 
The first four NHz-terminal sequences of the 
isolated two polypeptide chains of Ci^s (figs.2d and e) 
were determined by the SDS-dansyl-Edman micro- 
technique [lo] to be as follows; Glx-Ile-Thr-Met 
for the heavy chain and Ile-Ile-Gly-Gly for the 
light chain. 
In addition, the first two NHz-terminal sequence 
of human Cls was determined by the SDS-dansyl- 
Edman technique to be Glx-Ile. 
These results indicate that the heavy chain is 
Table 1 
Purification of 6 
Purification Step 
Total 
volume 
(ml) 
Total Total Specific 
protein activitya activity 
(14 280 nm) (units) (units/A280 nm) 
Plasma 230 15,890 N.D.b - 
Polyethylene 
Defibrination f 
ycol precipitateC 41 710 16.0 0.02 
41 189 15.3 0.08 
IgGSepharose 34 15.1 7.1 0.47 
DEAE-cellulose 43 1.3 5.0 3.84 
CE was determined by measuring the esterase activity with ATEE as the substrate [6]. One unit of 
CG is defined as the activity capable of hydrolyzing 1 pmole of the ester per min at 37°C. 
The exact content of &or Cls can not be determined. 
Proteins precipitated from ACD-plasma at 4.5% (w/v) polyethylene glycol concentration were 
collected by centrifugation, washed with 200 ml of 0.05 M NaCl and then dissolved in 0.02 M Tris- 
HCl buffer, pH 8.5, containing 0.15 M NaCl [ 131. 
Fibrinogen, the major constituent of polyethylene glycol precipitate, was remove-d as fibrin clot by 
the addition of CaCl, [ 131. 
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Fig.1. Purification of CG. a) The Cifraction prepared from 
230 ml of ACD-human plasma with polyethylene glycol [ 131 
was applied to a column (1.5 X 4 cm) of IgG-Sepharose 6B 
[9] equilibrated with 0.02 M Tris-HCl buffer, pH 8.5, 
containing 0.075 M NaCl and 5 mM CaCl,. After washing the 
column with the equilibration buffer, the column was eluted 
with 100 ml of 10 mM EDTA in 0.02 M Tris-HCl buffer, 
pH 8.5, containing 0.075 M NaCl and with 50 ml of 10 mM 
diaminobutane in the buffer. Fractio_ns of each 5 ml were 
collected at the cold room. b) The Cls fraction eluted with 
EDTA was applied to a column (1.5 X 5 cm) of DEAE- 
cellulose (DE-52) equilibrated with 0.02 M Tris-HCl buffer, 
pH 8.5, containing 0.075 M NaCl and 5 mM EDTA. After 
washing the column with 50 ml of the equilibration buffer, 
the column was eluted by linear gradient increase of NaCl 
concentration with each 200 ml of 0.075 M and 0.30 M 
NaCl in the buffer. Fractions of each 5 ml were collected at 
the cold room. Fractions, 42-50, were pooled and used as 
the purified Cg. 
derived from the NH,-terminal portion of the 
zymogen Cls molecule and that the light chain, which 
is derived from the remaining COOH-terminal portion 
of Cls, has a new NH*-terminal sequence homologous 
to those of other mammalian serine proteases. 
bcde 
Fig.2. Electrophoretograms. Purified Cls was electrophoresed 
with (a) 5% polyacrylamide gel [ 151, (b) 0.2% SDS-5% poly- 
acrylamide gel [ 121 and (c) 0.2% SDS-S% polyacrylamide gel 
after treatment with 0.1 M 2-mercaptoethanol. The isolated 
heavy (d) and light (e) chains of CG were electrophoresed as 
in (b). Proteins were stained with Coomassie Blue. 
4. Discussion 
The present experiments provide informations on 
the molecular events associated with the activation 
of human Cls. 
The first four NH*-terminal sequence of the light 
chain of 6shows homology with those of other 
serine proteases; Ile-Val-Gly-Gly for bovine trypsin 
[ 161, plasmin [ 171 and Factor Xa [ 18 1, and Ile-Val- 
(Asn or Glu)-Gly for bovine chymotrypsin [ 191 or 
thrombin [ 201. The newly appeared a-amino group 
on isoleucine is essential for the proteolytic activity 
of bovine trypsin [21,22], chymotrypsin [23] and 
thrombin [ 241, so the cleavage of a specific peptide 
bond, X-Ile, in the zymogen Cls molecule is probably 
an essen$il step for the formation of functionahy 
active Cls. Considering that Cif has a specificity 
similar to that of trypsin (3), the amino acid ‘x’ in 
the cleaved peptide bond is probably Arg or Lys. 
So, the molecular event associated with the activa- 
tion of human Cls can be written as follows: 
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Cls 
r---- s-s Glx-Ile-Thr-Met -----------Arg(Lys)-Ile-Ile-Gly-Gly-------- 
Cls 
1 
I S-S I 
Glx-Ile-Thr_Met ___I______ lle-Ile-Gly-Gly--‘------ 
heavy chain, 6.8 X lo4 daltons light chain, 3.4 X lo4 daltons 
Although the activation reaction of Cls is very 
similar to those of other zymogens, it should be 
emphasized that the cleavage of an NH*-terminal 
peptide does not occur during the activation of Cls 
to CL. This is in contrast to the activation reaction 
of other zymogens; the NH?-terminals of bovine 
trypsinogen [25], Factor X [ 181 and Factor XIII 
[26] are released as the ‘activation peptide’ in 
accompanied with the formation of active enzymes, 
and that of human plasminogen [27] is released as 
the ‘pre-activation peptide’ prior to the concomitant 
cleavage of the sensitive peptide bond necessary for 
the formation of active plasmin. 
As additional evidence on homology of CE with 
other serine proteases, Barkas et al. [28] recently 
reported that the DFP-sensitive active site of CL 
resides in the light chain and the ammo acid sequence 
surrounding the active site seems to be similar to 
those of chymotrypsin and thrombin. 
Acknowledgements 
The authors thank Professor T. Suzuki, Institute 
for Protein Research, Osaka University, for his 
interest in our work. We also thank Dr S. Kimura for 
his advice regarding the dansyl-Edman technique. 
This work was supported by a grant from Houansha, 
Japan. 
References 
111 
121 
131 
[41 
Lepow, I. H., Naff, G. B., Todd, E. W., Pensky, J. and 
Hinz, C. F. (1963) J. Exp. Med. 117,983-1008. 
Valet, C. and Cooper, N. R. (1974) J. Immunol. 112, 
1667-1673. 
Naff, G. B. and Ratnoff, 0. D. (1968) J. Exp. Med. 
128,571-593. 
Sakai, K. and Stroud, R. M. (1973) J. Immunol. 110, 
1010-1020. 
1:ebruary 1975 
[S] Valet, G. and Cooper, N. R. (1974) J. Immunol. 112, 
339-350. 
[6] Heines, A. L. and Lepow, I. II. (1964) J. Immunol. 94. 
456-467. 
[7] Robbins, K. C., Bernabe, P., Arzadon, L. and Summaria, 
[81 
[91 
IlO1 
[Ill 
[I21 
I131 
[I41 
Ll51 
1161 
[I71 
iI81 
[I91 
I-201 
[211 
[221 
v31 
1241 
1251 
I261 
1271 
I281 
L. (1972) J. Biol. Chem. 247, 6757-6762. 
Titani, K., Hermodson, M. A., Fujikawa, K., Ericsson, 
L. H., Walsh, K. A., Neurath, H. and Davie, E. W. (1972) 
Biochemistry 11,4899-4903. 
Bing, D. II. (1971) J. Immunol. 107, 124771249. 
Weiner, A. M., Platt, T. and Weber, K. (1972) .I. Biol. 
Chem. 247, 3242-3251. 
Kimura, S. (1974) Japan Analyst 23, 563-575. 
Weber, K. and Osborn, M. (1969) J. Biol. C hem. 244. 
440664412. 
Nagasawa, S., Takahashi, K. and Koyama, .I. I 1974) 
FEBS Lett. 41, 280-282. 
Sledge, C. R. and Bing, D. Ii. (1973) J. Immunoi. 111, 
661-666. 
Davis, B. J. (1964) Ann. N.Y. Acad. Sci. 121.404-427. 
Walsh, K. A. and Neurath, H. (1964) Proc. Natl. Acad. 
Sci. 52, 884-889. 
Nagasawa, S. and Suzuki, T. (1970) Biochem. Biophyc. 
Res. Commun. 41,562-567. 
Fujikawa, K., Legaz, M. E. and Davie. E. W. (I 972) 
Biochemistry 11,4892-4898. 
Hartley, B. S. and Kauffman, D. L. (1966) Biochem. J. 
101, 2299231. 
Magnusson, S. (1970) Thromb. Diath. Heamor. suppl. 
38,97-104. 
Scrimger, S. T. and Hoffman, T. (1967) J. Biol. Chem. 
242, 2528-2533. 
Robinson, N. C., Neurath, H. and Walsh, K. A. (1973) 
Biochemistry 12, 420-426. 
Dixon, J. W. and Hoffman. T. (1970) Can. J. Biochem. 
48,671-681. 
Magnusson. S. and Hoffman, T. (1970) Can. J. Biochem. 
48,432-437. 
Davie, E. W. and Neurath, H. (1955) J. Biol. Chem. 
212,507-514. 
Nakamura, S., lwanaga, S., Suzuki, T., Mikuni, Y. and 
Konishi, K. (1974) Biochem. Biophys. Rcs. (‘ommun. 
58, 250-256. 
Rickili, E. and Otavsky, W. I. (1973) Biochim. Biophys. 
Acta 295, 381-384. 
Barkas, T., Scott, K. and Fothergill, J. E. (1973) 
Biochem. Sot. Trans. 1, I21 9- 1220. 
333 
